Attendees will hear from NICHD’s Dr. Tracey Rouault about the potential to formulate the compound, Tempol, into a preventative and oral treatment for COVID-19. The replication of the SARS-CoV-2’s genome [….]
Attendees will hear about licensing and co-development opportunities from the NCI’s Dr. Mitchell Ho for a potential therapeutic treatment for COVID-19, “Single Domain Antibodies Targeting SARS-CoV2 for Treating Covid-19.” There [….]
INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease
INOVIO (NASDAQ: INO), a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that the company has dosed the first Phase 2 trial subject in its quest to develop the first vaccine against the Middle East Respiratory Syndrome (MERS). INOVIO’s Phase 2 trial is designed to evaluate INO-4700, its DNA vaccine candidate for the prevention of MERS, a disease in the coronavirus family for which there are no approved vaccines.
Gaithersburg’s Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant. The agreement covers the purchase of up to 100 million doses of the vaccine with the option for an additional 100 million doses through 2023.
IMMU 102 – Emerging Coronaviruses. Emerging microbial pathogens are of increasing concern both nationally and internationally with the potential to cause widespread morbidity and mortality at an unprecedented level. The [….]
UM School of Medicine and School of Pharmacy Researchers Identify Promising New Compounds to Potentially Treat Novel Coronaviruses | University of Maryland School of MedicinePublished on :
Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The [….]
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More.
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More. The coronavirus pandemic and its impacts are changing daily and are hard to [….]
“Claudia Towles owner of aMuse Toys said her company adjusted with the closure of non-essential businesses and shifted to retool the business for online orders, curbside pickup, and local deliveries.” [….]
Maryland’s Medicinal Cannabis Industry Responds to Ensure Safe Patient Access During COVID-19 Crisis
Maryland’s Medicinal Cannabis Industry Responds to Ensure Safe Patient Access During COVID-19 Crisis Amid unprecedented uncertainty, industry insiders encourage staff safety and stakeholder education for patient access Dispensaries, growers, processors [….]
Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages April 28, 2020 Longhorn Vaccines & Diagnostics, located in Bethesda, Maryland, is a privately-held, veteran-run company that develops [….]